Xencor | Attività Correnti



Current Assets Cambiamento Data
AbbVie USD 27.68B 2.09B 2025-03
Alnylam Pharmaceuticals USD 3.64B 375.44M 2025-06
Amgen USD 26.73B 195M 2025-06
Arrowhead Research USD 946.92M 188.3M 2025-06
AstraZeneca USD 28.94B 2.8B 2025-06
Biogen USD 7.97B 341.7M 2025-06
Bristol-Myers Squibb USD 33.22B 2.44B 2025-06
Cytokinetics USD 886.54M 69.51M 2025-06
GlaxoSmithKline GBP 17.67B 412M 2025-06
J&J USD 71.55B 15.66B 2025-03
MacroGenics USD 217.49M 4.71M 2024-12
Merck USD 37.07B 1.56B 2025-06
Novartis USD 25.94B 831M 2025-06
Pfizer USD 43.7B 2.16B 2025-06
Regeneron Pharmaceuticals USD 16.86B 712.2M 2025-06
Roche Holding CHF 40.04B 6.41B 2024-12
Xencor USD 513.15M 8.12M 2025-06


Xencor Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.